# Treatment of Patients With Diabetic Kidney Disease

> **NCT06187493** · NA · UNKNOWN · sponsor: **Assiut University** · enrollment: 70 (estimated)

## Conditions studied

- Diabetic Kidney Disease

## Interventions

- **DRUG:** lisinopril, enalapril
- **DRUG:** dapagliflozin, empagliflozin

## Key facts

- **NCT ID:** NCT06187493
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-01-01
- **Primary completion:** 2025-01-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2024-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06187493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06187493, "Treatment of Patients With Diabetic Kidney Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06187493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*